BriaCell to Present at Global Cancer Immunotherapy Meeting
PHILADELPHIA and VANCOUVER, British Columbia – BriaCell Therapeutics Corp. (NASDAQ: BCTX, BCTXW) (TSX: BCT) is a leading clinical-stage biotechnology company dedicated to developing innovative immunotherapies that aim to transform cancer treatment. The firm has announced an important poster presentation at the upcoming Society for Immunotherapy of Cancer (SITC) Annual Meeting.
Presentation Details
The SITC 39th Annual Meeting is scheduled for November 6-10, 2024. BriaCell is eager to participate in this significant conference, which gathers experts in cancer research and treatment. During the event, the company will showcase its latest findings on promising targeted immunotherapy candidates, particularly those designed to assist patients with breast and prostate cancers.
Highlights from the Speaker
Dr. Miguel Lopez-Lago, BriaCell’s Chief Scientific Officer, shared his excitement about the opportunities presented by this conference. "We are thrilled to be invited to present our data at this prestigious event," he remarked. He emphasized the importance of exploring immunotherapy options that could potentially change the landscape of treatment for these cancers, leading to significant improvements in patient care.
Session Details
Here are the specifics regarding the presentation session:
Location: Exhibit Halls A B, George R. Brown Convention Center, Houston, TX
Date and Time: Friday, Nov. 8, 2024, 9:00 AM - 7:00 PM CST
Following the presentation, attendees will have the opportunity to access a copy of the poster on BriaCell’s official website.
About BriaCell Therapeutics
BriaCell Therapeutics is recognized for its commitment to developing pioneering immunotherapies. The company is focused on advancing research to provide more effective treatments for cancer patients. Those interested can find additional information about their initiatives and technologies on their website.
Looking Ahead: Future Innovations
As BriaCell continues its journey, the company remains dedicated to expanding the possibilities in cancer treatment. The ongoing research and development of targeted immunotherapies indicate promising prospects for redefining cancer care. BriaCell's involvement in prominent conferences like SITC fosters valuable networking and knowledge-sharing opportunities, paving the way for advancements that could benefit patients around the globe.
Contact Information for the Company
The vision and credibility of BriaCell are driven by its dedicated leadership. For more insights, you can reach out to the team:
William V. Williams, MD
President & CEO
1-888-485-6340
info@briacell.com
Frequently Asked Questions
What is BriaCell Therapeutics known for?
BriaCell is known for its innovative approach to developing immunotherapies aimed at transforming cancer treatment.
When is the SITC Annual Meeting?
The SITC Annual Meeting will take place from November 6-10, 2024.
Where will BriaCell present their findings?
BriaCell will present at the George R. Brown Convention Center located in Houston, TX.
What types of cancer is BriaCell focusing on?
BriaCell is currently focusing on developing treatments for breast and prostate cancer.
How can I learn more about BriaCell’s research?
For more information about BriaCell's ongoing research and presentations, you can visit their official website.